155. Acquired aphasia with convulsive disorder Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 2 - (DrugBank : 2) / Drug target genes : 29 - Drug target pathways : 14
Drugs and their primary sponsors and trial info
Acetazolamide
Mayo Clinic
2016 Phase 2/Phase 3 NCT02904265 United States;
Diazepam
Mayo Clinic
2016 Phase 2/Phase 3 NCT02904265 United States;
Mayo Clinic
2016 Phase 2/Phase 3 NCT02904265 United States;
Diazepam
Mayo Clinic
2016 Phase 2/Phase 3 NCT02904265 United States;